Research Article
A Novel Inflammation-Based Stage (I Stage) in Patients with Resectable Esophageal Squamous Cell Carcinoma
Table 1
Clinicopathological characteristics for patients with ESCC.
| | | Cases (, %) |
| | Age (years, mean ± SD) | 59.1 ± 7.9 | | Gender | | | Female | 42 (13.0) | | Male | 281 (87.0) | | Tumor length (cm, mean ± SD) | 4.3 ± 1.9 | | Tumor location | | | Upper | 17 (5.3) | | Middle | 151 (46.7) | | Lower | 155 (48.0) | | Differentiation | | | Good | 44 (13.6) | | Moderate | 216 (66.9) | | Poor | 63 (19.5) | | T grade | | | T1 | 55 (17.0) | | T2 | 55 (17.0) | | T3 | 179 (55.4) | | T4 | 34 (10.6) | | N stage | | | N0 | 174 (53.9) | | N1 | 87 (26.9) | | N2 | 37 (11.5) | | N3 | 25 (7.7) | | TNM stage | | | I | 81 (25.1) | | II | 104 (32.2) | | III | 138 (42.7) | | I stage | | | I0 | 112 (34.7) | | I1 | 97 (30.0) | | I2 | 66 (20.4) | | I3 | 48 (14.9) | | CRP (mg/L, mean ± SD) | 9.7 ± 13.5 | | NLR (mean ± SD) | 3.3 ± 2.8 | | PLR (mean ± SD) | 160.9 ± 70.6 |
|
|
